2seventy bio is now part of Bristol Myers Squibb. Follow our progress in #CARTcelltherapy @Bristol Myers Squibb or www.bms.com.
| Website | http://www.bms.com |
| Revenue | $46.5 billion |
| Employees | 121 (121 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology |
| Keywords | Immunotherapy, Immuno Oncology, Cell Therapy, Oncology Research, Cancer Treatment, Cancer Research, Cancer Therapies, Oncology Therapeutics, Cell Therapy Development, Biotechnology, Biopharma, Disruptive Technology, Precision Medicine, Pharmaceutical, Innovative Treatments, Drug Development, New Therapies, Therapeutic Development, Clinical Trials, Clinical Stage |
Looking for a particular 2seventy bio employee's phone or email?
The 2seventy bio annual revenue was $46.5 billion in 2026.
Chip Baird is the CEO of 2seventy bio.
121 people are employed at 2seventy bio.
2seventy bio is based in Cambridge, Massachusetts.